Indefinite Delivery Contract SPE2DR25D9133

The federal contract IDV award SPE2DR25D9133 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business, with the Defense Logistics Agency (DLA). The contract, valued at $4,999,999, covers the provision of a comprehensive range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the medical supply needs of military health facilities worldwide.

The contract was awarded under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement, which seeks to establish multiple regional prime vendor contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet. The contract has a base period of 30 months and three 30-month option periods, with an estimated total value of $30.3 billion across all regional awards. DMS Pharmaceutical Group's IDC is a firm fixed-price requirements contract that enables the DLA to issue delivery orders for a diverse portfolio of pharmaceutical products to support normal day-to-day operations, contingency, and war readiness requirements at both CONUS and OCONUS locations.